Merck & Co., Inc.

MRK · Healthcare

About Merck & Co., Inc.

Merck & Co., Inc. (MRK) has been publicly traded since 1962, making it a 64-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in Rahway, United States and employs approximately 73,000 people. With a market capitalization of $286 billion, MRK is one of the largest publicly traded companies.

Key Statistics

Current Price
$116.69
Market Cap
$288.50B
52-Week High
$125.14
52-Week Low
$73.31
Sector
Healthcare
Industry
Drug Manufacturers - General

$1,000 Invested

1 Year
$1,278
+28%
3 Years
$1,188
+19%
5 Years
$1,933
+93%
10 Years
$3,164
+216%
Since IPO
$1,817,191
+181619%

Monthly Returns Heatmap

Annual Returns

Avg Return
+15.59%
Best Year
1991 (+88.89%)
Worst Year
2008 (-45.33%)
Positive Years
48/64
Year Return Start End
2026 +10.86% $105.26 $116.69
2025 +9.79% $95.88 $105.26
2024 -6.26% $102.28 $95.88
2023 +1.01% $101.26 $102.28
2022 +49.42% $67.77 $101.26
2021 +1.75% $66.60 $67.77
2020 -7.20% $71.77 $66.60
2019 +22.27% $58.70 $71.77
2018 +39.95% $41.94 $58.70
2017 -1.49% $42.57 $41.94
2016 +15.05% $37.00 $42.57
2015 -3.89% $38.50 $37.00
2014 +16.93% $32.92 $38.50
2013 +26.83% $25.96 $32.92
2012 +13.14% $22.95 $25.96
2011 +9.56% $20.94 $22.95
2010 +2.91% $20.35 $20.94
2009 +26.70% $16.06 $20.35
2008 -45.33% $29.38 $16.06
2007 +37.35% $21.39 $29.38
2006 +42.68% $14.99 $21.39
2005 +4.04% $14.41 $14.99
2004 -27.77% $19.95 $14.41
2003 -11.20% $22.46 $19.95
2002 -1.21% $22.74 $22.46
2001 -35.96% $35.51 $22.74
2000 +41.76% $25.05 $35.51
1999 -7.49% $27.08 $25.05
1998 +41.30% $19.16 $27.08
1997 +35.65% $14.13 $19.16
1996 +23.94% $11.40 $14.13
1995 +76.61% $6.45 $11.40
1994 +14.85% $5.62 $6.45
1993 -18.33% $6.88 $5.62
1992 -20.31% $8.63 $6.88
1991 +88.89% $4.57 $8.63
1990 +18.94% $3.84 $4.57
1989 +37.47% $2.80 $3.84
1988 +11.95% $2.50 $2.80
1987 +29.98% $1.92 $2.50
1986 +84.58% $1.04 $1.92
1985 +50.10% $0.69 $1.04
1984 +7.68% $0.64 $0.69
1983 +10.19% $0.58 $0.64
1982 +3.61% $0.56 $0.58
1981 +3.07% $0.55 $0.56
1980 +21.27% $0.45 $0.55
1979 +10.05% $0.41 $0.45
1978 +25.58% $0.33 $0.41
1977 -16.23% $0.39 $0.33
1976 +0.45% $0.39 $0.39
1975 +6.26% $0.37 $0.39
1974 -16.59% $0.44 $0.37
1973 -8.09% $0.48 $0.44
1972 +45.39% $0.33 $0.48
1971 +27.85% $0.26 $0.33
1970 -10.76% $0.29 $0.26
1969 +28.29% $0.22 $0.29
1968 +8.98% $0.21 $0.22
1967 +12.11% $0.18 $0.21
1966 +11.03% $0.17 $0.18
1965 +45.04% $0.11 $0.17
1964 +39.31% $0.08 $0.11
1963 +43.39% $0.06 $0.08

Valuation

MRK currently trades at a trailing P/E ratio of 15.9, which is considered moderate relative to the broader market. The forward P/E of 11.9 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 5.4. The price-to-sales ratio is 4.4.

Dividends

Merck & Co., Inc. pays a dividend to shareholders with a current yield of 2.94%. This translates to $3.40 per share annually. The payout ratio of 45% indicates sustainable dividend coverage.

Risk & Volatility

MRK has a beta of 0.26, indicating it is less volatile than the overall market. The stock's 52-week range is $73.31 to $125.14, and it currently trades near its 52-week high.

Analyst Ratings

Based on 27 analyst opinions, MRK has a consensus "buy" rating. The average price target of $127.78 suggests 10.5% upside from current levels.

Frequently Asked Questions

What does Merck & Co., Inc. do?

Merck & Co., Inc. is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Rahway, United States.

What sector is MRK in?

MRK operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

When did MRK go public?

Merck & Co., Inc. went public in 1962, making it a 64-year-old public company as of 2026.

How much would $1,000 invested in MRK 5 years ago be worth today?

A $1,000 investment in MRK five years ago would be worth approximately $1,933 today, representing a 93.3% return.

Does MRK pay dividends?

Yes, Merck & Co., Inc. pays a dividend with a current yield of 2.94%, which is $3.4 per share annually.

What is MRK's market cap?

Merck & Co., Inc. has a market capitalization of $286 billion, classifying it as a mega-cap company.

What is MRK's P/E ratio?

MRK has a trailing P/E ratio of 15.9 and a forward P/E of 11.9, which measures how much investors are paying per dollar of earnings.

Is MRK a buy, hold, or sell?

Based on 27 opinions, MRK has a consensus "buy" rating. The average price target is $127.78.

Last updated: 3/14/2026